Further evidence for interaction between angiotensin II and dopamine receptors (experiments on apomorphine stereotypy)

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 5, 1998, Pages 419-424

  Tchekalarova, J ^a   Georgiev, V ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Angiotensin II (AII); Apomorphine stereotypy; DA receptors; DuP 753; Sarilesin; Sarmesin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; APOMORPHINE; DOPAMINE RECEPTOR; LOSARTAN POTASSIUM; SARMESIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; STEREOTYPY;

ANGIOTENSIN II; ANIMALS; APOMORPHINE; LOSARTAN; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; STEREOTYPED BEHAVIOR;

EID: 0031831054     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.5.485703     Document Type: Article

References (31)

1. Bunnemann, B., Fuxe, K., Ganten, D. The renin-angiotensin system in the brain: an update, Regulatory Peptides 1993, 46: 487-509.
2. Georgiev, V., Stancheva, S., Kambourova, T., Getova, D. Effect of angiotensin II on the Vogel conflict paradigm and on the content of dopamine and noradrenaline in rat brain. Acta Physiol Pharmacol Bulg 1990, 16: 32-7.
3. Georgiev, V., Kambourova, T. Behavioural effects of angiotensin II in the mouse following MTPT administration. Gen Pharmacol 1991, 22: 625-30.
4. Georgiev, V., Tanaka, T., Tsuda, A. et al. Effects of angiotensin II on regional brain noradrenaline metabolism in nonstressed and stressed rats. Kurume Med J 1992, 39: 235-44.
5. Tsuda, A., Tanaka, T., Georgiev, V., Emoto, H. Effects of angiotensin II on behavioural responses of defensive burying paradigm in rats. Pharmacol Biochem Behav 1992, 43: 729-32.
6. Georgiev, V., Kambourova, T. Interaction between angiotensin II and dopaminergic mechanisms at the convulsive-seizure threshold. Comptes rendus de l'Academie Bulgare des Sciences 1984, 37: 391-3.
7. Georgiev, V., Petkova, B., Kambourova, T. Adaptive changes in the effects of angiotensin II on the convulsive seizure threshold in cases of altered sensitivity of dopamine receptors. Meth Find Exp Clin Pharmacol 1988, 10: 295-9.
8. Georgiev, V., Getova, D., Opitz, M. Mechanisms of the angiotensin II effects on the exploratory behavior of rats in open field I. Interaction of angiotensin II with saralasin and catecholaminergic drugs. Meth Find Exp Clin Pharmacol 1987, 9: 297-301.
9. Yonkov, D., Georgiev, V., Opitz, M. Participation of angiotensin II in learning and memory. II. Interaction of angiotensin II with dopaminergic drugs. Meth Find Exp Clin Pharmacol 1986, 8: 203-6.
10. Georgiev, V., György, L., Getova, D., Markovska, V. Some central effects of angiotensin II. Interaction with dopaminergic transmission. Acta Physiol Pharmacol Bulg 1985, 11: 19-26.
11. Banks, A., Dourish, C.T. The angiotensin receptor antagonists DuP 753 and WL 19 block apomorphine-induced stereotypy in the rat. Br J Pharmacol 1991, 104 (Suppl.): 63.
12. 2 receptor agonists in the rat. Br J Pharmacol 1992, 105 (suppl.): 89.
13. Matsoukas, J.M., Goghari, M.H., Scanlon, M.N., Franklin, J., Moore, G.J. Synthesis and biological activities of analogues of angiotensin II and III containing O-methyltyrosine and D-tryptophan. J Med Chem 1985, 28: 780-2.
14. Georgiev, V., Matsoukas, J.M., Georgieva, D., Tchekalarova, J., Todorov, I. Influences of sarmesin on some dopamine related behaviours. LIPS 1996, 3: 185-90.
15. Ernst, A.M. Mode of action of apomorphine and dexamphetamine in gnawing compulsion in rats. Psychopharmacology 1967, 10: 316-26.
16. Ungerstedt, U. Central dopamine mechanisms and unconditioned behaviour. In: The Neurobiology of Dopamine. Horn, A.S., Korf, J., Westerhk, C. (Eds.) Academic Press: London 1979, 577-96.
17. Kelly, P.H., Seviour, P.W., Iversen, S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus callosum. Brain Res 1975, 94: 507-22.
18. Mendelsohn, A.O., Jenkins, T.A., Berkovic, S.F. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res 1993, 613: 221-9.
19. Dwoskin, K.P., Jewell, A.L., Cassis, L.A. DuP 753, a nonpeptide angiotensin III receptor antagonist, alters dopaminergic function in the rat striatum. Naunyn Schmiedeberg's Arch Pharmacol 1992, 345: 153-9.
20. Braszko, J.J., Holy, Z.Z., Kupryszewski, G., Witczuk, B. Effect of angiotensin II, its 2-8, 3-8, 4-8 fragments and saralasin on the level and turnover of dopamine in the striatum and olfactory tubercle of the rat. Asia Pacific J Pharmacol 1991, 6: 243-247.
21. Allen, A.M., Paxinos, G., McKinley, M.G., Chai, S.Y., Nelsohn, O. Localization and characterization of angiotensin II receptor binding sites in the human basal ganglia, thalamus, midbrain, pons and cerebellum. J Comp Neurol 1991, 312: 291-8.
22. Allen, A.M., Macgregar, D.P., Chai, S.Y., Donnan, G.A., Kaczmarczyk, S.J, Richardson, R.M., Ireton, J., Mendelsohn, A.O. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann Neurol 1992, 32: 339-44.
23. Jenkins, T.A., Chai, S.Y., Howells, D.W., Mendelsohn, A.O. Intrastriatal angiotensin II induces turning behavior in 6-hydroxydopamine lesioned rats. Brain Res 1995, 691: 213-6.
24. Scanlon, M.N., Moore, G.J. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin. Pharmacology 1988, 37: 137-47.
25. Moore, G.J., Matsoukas, J.M., Scanlon, M.N., Franklin, Y.J., Goghari, M.N. On the mechanisms of action of two classes of angiotensin antagonists at smooth muscle receptor. Proc West Pharmacol Soc 1984, 27: 377-83.
26. 8] ANG II for receptor blockade. J Pharmcol Methods 1988, 20: 207-24.
27. Moore, G.J., Scanlon, A.N. Methods for analyzing and interpreting cooperativity in dose-response curves I. Antagonist effects on angiotensin receptors in smooth muscle. Gen Pharmacol 1989, 20: 193-8.
28. Hondrelis, J., Matsoukas, J.M., Cordopatis, P., Vanter, R.C., Franklin, K.J., Moore, G.J. Synthesis and biological activities of angiotensin II and sarmesin analogues containing cyclohexylalanine. Int J Peptide Protein Res 1991, 37: 21-6.
29. 3H-angiotensin II binding to zona glomerulosa cells by several analogs. Arch Pharmcodyn 1977, 228: 15-22.
30. Turner, R.J., Matsoukas, J.M., Moore, G.J. Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinase fluorescence lifetime and biological activity. Biochimica Biophysica Acta 1991, 1065: 21-8.
31. Wong, P.C., Price, W.A., Chin, A.T. et al. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990, 252: 719-25.